We read with interest the work by Kimball and colleagues, "Allograft TNFโค and IL16 Polymorphisms Influence HCV Recurrence and Severity After Liver Transplantation," which appears in the February 2006 issue of Liver Transplantation. 1 We would like to add a finding from our recent study that may shed
The effect of recurrence of HCV infection of life after liver transplantation
โ Scribed by M. De Bona; G. Rupolo; P. Ponton; R. M. Iemmolo; P. Boccagni; C. Destro; M. Ermani; R. Naccarato
- Publisher
- Springer
- Year
- 1998
- Tongue
- English
- Weight
- 443 KB
- Volume
- 11
- Category
- Article
- ISSN
- 0934-0874
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
## Identification of the hepatitis C virus-the main cause of posttransfusion and sporadic non -A, non-B hepatitisand the development of a diagnostic serological test have allowed us to study possible recurrence of this type of hepatitis after liver transplantation. Six of 34 consecutive transplant
1. Early recurrence of hepatitis C is universal. 2. Typical histopathologic features of hepatitis C virus (HCV) and acute allograft rejection (AAR) exist. 3. Early recurrent HCV may be differentiated from AAR. 4. Liver biopsy plays a role in diagnosing HCV and AAR. 5. Risk factors for recurrent HCV
Virus-specific CD8+ T cells play a major role in antiviral immune defenses; their significance in the transplant setting, however, is unclear. In the present study, we asked whether hepatitis C virus (HCV)-specific CD8+ T cells were detectable in the presence of an immunosuppressive treatment and wh